What is Immune Therapeutics, Inc.'s annual revenue?

Immune Therapeutics, Inc. (IMUN) reported annual revenue of $0 in its most recent fiscal year.

What is Immune Therapeutics, Inc.'s net profit?

Immune Therapeutics, Inc. (IMUN) reported net profit of $-6.0M in its most recent fiscal year.

What is IMUN EV/EBITDA?

Immune Therapeutics, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.52.

OTC · Financial Statements

Immune Therapeutics, Inc. (IMUN) Financial Statements

$0.09 OTC: IMUN Market Cap $7.78M

Immune Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-6.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-4.0M	$-3.0M	$-1.0M	$-1.0M	$-1.0M
Net Profit	$-8.0M	$-5.0M	$1.0M	$4.0M	$-6.0M
EPS	$-19.03	$-10.44	$2.40	$0.38	$-0.16
Op Margin	-3599.1%	—	—	—	—

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$0	$0	$0	$3.0M	$1.0M
Total Liabilities	$11.0M	$14.0M	$12.0M	$11.0M	$3.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$5.0M	$6.0M	$3.0M	$3.0M	$1.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-1.0M	$0	$0	$0	$-1.0M
Investing Cash Flow	$0	$0	$0	$0	$-1.0M
Financing Cash Flow	$1.0M	$0	$0	$1.0M	$1.0M
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$0	$0	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.52
FCF Yield	-5183.92%
Quick Ratio	0.01
Interest Coverage	-8.83
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

IMUN Overview IMUN Dividend Run Stock Screener